For: | Inayet N, Hayat J, Bano G, Poullis A. Gastrointestinal symptoms in acromegaly: A case control study. World J Gastrointest Pharmacol Ther 2020; 11(2): 17-24 [PMID: 32550042 DOI: 10.4292/wjgpt.v11.i2.17] |
---|---|
URL: | https://www.wjgnet.com/2150-5349/full/v11/i2/17.htm |
Number | Citing Articles |
1 |
Maria Fleseriu, Lisa B. Nachtigall, Susan L. Samson, Shlomo Melmed. Oral octreotide capsules for acromegaly treatment: application of clinical trial insights to real-world use. Expert Review of Endocrinology & Metabolism 2024; 19(4): 367 doi: 10.1080/17446651.2024.2363540
|
2 |
Gautami S Patel, Idan Grossmann, Kevin Rodriguez, Mridul Soni, Pranay K Joshi, Saawan C Patel, Devarashetty Shreya, Diana I Zamora, Ibrahim Sange. Acromegaly and the Colon: Scoping Beyond the Pituitary. Cureus 2021; doi: 10.7759/cureus.20018
|
3 |
Rafael Castellanos-Bueno, Alín Abreu-Lomba, Nathalia Buitrago-Gómez, Marcela Patiño-Arboleda, Doly Pantoja-Guerrero, Alex Valenzuela-Rincón, Henry M. Arenas-Quintero, Humberto I. Franco-Betancur, Alejandro Castellanos-Pinedo, Dinett Movilla-Castro, José M. Ocampo-Chaparro, Carlos A. Reyes-Ortiz, Alejandro Pinzón-Tovar. Clinical and epidemiological characteristics, morbidity and treatment based on the registry of acromegalic patients in Colombia: RAPACO. Growth Hormone & IGF Research 2021; : 101425 doi: 10.1016/j.ghir.2021.101425
|
4 |
Leandro Kasuki, Bernardo Maia, Mônica R. Gadelha. Acromegaly and Colorectal Neoplasm: An Update. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.924952
|
5 |
|
6 |
B. Maia, E. Madeira, M. R. Gadelha, L. Kasuki. Assessment of the frequency and risk factors for colorectal cancer in acromegaly. Endocrine 2024; doi: 10.1007/s12020-024-04099-2
|